Suvd Byambaa, Hideki Uosaki, Tsukasa Ohmori, Hiromasa Hara, Hitoshi Endo, Osamu Nureki, Yutaka Hanazono. Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9. Molecular therapy. Methods & clinical development. 2021. 20. 451-462
Tatsuya Anzai, Hiromasa Hara, Nawin Chanthra, Taketaro Sadahiro, Masaki Ieda, Yutaka Hanazono, Hideki Uosaki. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9. Methods in molecular biology (Clifton, N.J.). 2021. 2320. 247-259
Tomoyuki Abe, Hideki Uosaki, Hiroaki Shibata, Hiromasa Hara, Borjigin Sarentonglaga, Yoshikazu Nagao, Yutaka Hanazono. Fetal sheep support the development of hematopoietic cells in vivo from human induced pluripotent stem cells. Experimental hematology. 2021
PHENOTYPICAL CORRECTION OF X-SCID MICE AFTER CRISPR/CAS9-MEDIATED UNIVERSAL GENOME-EDITING THERAPY OF HEMATOPOIETIC STEM CELLS
(Frontiers in Genome Engineering 2019 2019)
ESTABLISHMENT OF SIMULTANEOUS TRIPLE-REPORTER SYSTEM FOR HDR/NHEJ/DSB
(Frontiers in Genome Engineering 2019 2019)